Valneva to present and hold investor meetings at the jefferies london healthcare conference

Saint- herb lain (france) , november 7 , 2 02 2 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announced that its chief executive officer thomas lingelbach and chief financial officer peter bÜhler will present and participate in 1-on-1 meetings with institutional investors at the jefferies london healthcare conference, to take place november 15-17, 2022 in london, england.
VALN Ratings Summary
VALN Quant Ranking